Document is current
Any future updates will be listed below
-
Authors
Cattaneo, Monica https://orcid.org/0000-0002-1866-5866
Aleksova, Aneta
Malovini, Alberto
Avolio, Elisa https://orcid.org/0000-0003-4801-8480
Thomas, Anita
Alvino, Valeria Vincenza
Kilcooley, Michael
Pieronne-Deperrois, Marie
Ouvrard-Pascaud, Antoine
Maciag, Anna https://orcid.org/0000-0001-6562-5640
Spinetti, Gaia https://orcid.org/0000-0001-7996-6809
Kussauer, Sophie
Lemcke, Heiko
Skorska, Anna
Vasudevan, Praveen
Castiglione, Stefania
Raucci, Angela
David, Robert
Richard, Vincent
Beltrami, Antonio Paolo https://orcid.org/0000-0002-0679-2710
Madeddu, Paolo
Puca, Annibale Alessandro https://orcid.org/0000-0002-0347-1460
- License Information
-
More Information
Article History
Received: 22 January 2023
Revised: 11 July 2023
Accepted: 17 July 2023
First Online: 15 August 2023
Competing interests
: AAP shares of LGV1 Inc. and have filed a patent. All the other authors declare that there is no competing interests.
: The clinical study was approved by the Local Ethics Committee (protocol n. 67/2015) and the informed consent was obtained from all subjects. All experimental procedures used in animal studies were compliant with the EU Directive 2010/63/EU and principles stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996). The protocols detailed below were prepared with support from the Experimental Design Assistant, a free resource from the National Centre for Replacement, Refinement, and Reduction of Animals in Research () under French National Legislation.
